Kenji Oku is an associate professor of the Department of Rheumatology and Infection Diseases at the Kitasato University, Japan. His interests have focused on both basic science and clinical research in SLE and the antiphospholipid syndrome.
Most recently, as the member of the standing committee of the APLAR, he and his colleagues published the Consensus Statements on the Management of SLE. Additionally, as fellow of Japan College of Rheumatology (JCR), he holds various senior level positions in the JCR, including the executive director of the standing committee of the Japanese clinical guidelines of SLE and the senior member of the task force against COVID-19.